-
2024TIBCS Channel會前訪談特輯(1)-Mark Pegram & Leif Ellisen精選課程內科用藥專業 1.0修課人數:85
2024TIBCS Channel會前訪談特輯(1)聚焦癌症領域的突破性進展
歡迎收看我們的專訪! 與來自Stanford University 的Mark Pegram教授和Massachusetts General Hospital的Leif Ellisen教授,一同探討最新的癌症研究突破。
此次訪談由長庚醫院楊展庚醫師及高若雲醫師共同主持,將帶領我們深入了解生物標誌物、腫瘤微環境及個人化療法的未來發展。
這場訪談為TIBCS 2024的精彩內容揭開序幕,讓您搶先掌握癌症治療的未來趨勢!
贊助廠商more -
What can we expect more from CDK46i in HR+HER2- mBC treatment精選課程內科用藥專業 1.0修課人數:147
This session will explore more details from Pharmacodynamics to senescence and cell metabolism. Comparing 3 CDK4/6i to each other, we can find out the differences leading to various carry over effects.
贊助廠商 台灣諾華股份有限公司more -
2024乳房醫學線上研討會(3)考試必讀2024乳房醫學線上研討會(3)甄審考試放射影像其他專業 4.0修課人數:247
2024乳房醫學線上研討會,今年度共3場會議,將於6/28, 8/02, 09/06,在乳e學院線上進行,第三場上架!歡迎各位踴躍上網閱讀!
贊助廠商more -
2024乳房醫學線上研討會(2)考試必讀2024乳房醫學線上研討會(2)甄審考試內科用藥其他專業 5.0修課人數:254
2024乳房醫學線上研討會,今年度共3場會議,將於6/28, 8/02, 09/06,在乳e學院線上進行,第二場上架!歡迎各位踴躍上網閱讀!
贊助廠商more -
Right Choice with Right Treatment for Pre-menopausal HR+HER2-mBC-Achieving Overall Survival and Maintain QoL精選課程內科用藥專業 1.0修課人數:140
We would like to review HR+HER2- mBC pre-menopausal population focus trials and real-world experience from TSGH in treating premenopausal patient. The overview of the study can refresh the scope and mindset of recent approved premenopausal patient reimbursement in Jan. 2024.
贊助廠商 台灣諾華股份有限公司more -
2024乳房醫學線上研討會(1)考試必讀2024乳房醫學線上研討會(1)甄審考試外科手術其他專業 5.0修課人數:282
2024乳房醫學線上研討會,今年度共3場會議,將於6/28, 8/02, 09/06,在乳e學院線上進行,歡迎有意報考乳房專科醫師的學員及各位會員踴躍上網觀看影片!
贊助廠商more